Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Australian Healthcare Herald.
Press releases published on July 1, 2025

PharmStars Announces the First Startup from Australia to Graduate from its Accelerator Program: Preview Health
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of Preview Health, the first Australian startup in the program. BOSTON, MA, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- PharmStars, the pharma-focused …

Global Recombinant Proteins Market To Reach $5.2 Billion By 2032 With A Growth Rate Of 7.7%
PORTLAND, GA, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- The global recombinant proteins market size was valued at $2.5 billion in 2023, and is projected to reach $5.2 billion by 2033, growing at a CAGR of 7.7% from 2024 to 2033. Key factors …

Kepner-Tregoe ANZ Officially Launches Under New Licensee, Ishita Terry
Continuing a Legacy of Excellence with a Renewed Focus on Regional Growth and Client Success PRINCETON, NJ, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- As of July 1, 2025, VantEdge Plus Pty Ltd, led by Ishita Terry, is officially operating as the …

Pet Acoustics Launches Groundbreaking Pet Acoustics+ App: First Mobile Hearing Test & Calming Music Platform for Pets
Pet Acoustics+ app launches with the first mobile hearing test for pets and calming music to ease anxiety, fears, …

Marie Castro Hamilton Shares Journey From Silence to Empowerment in #1 International Best-Selling Book
Marie Castro Hamilton’s Story of a Pivotal Teen Experience and Decades-Later Healing Is Now Told in a #1 Bestselling Book FONTANA, CA, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- Marie Castro Hamilton, a successful Entrepreneur, Reiki Master, and …

SOMAÍ and Lusófona Publish Peer-Reviewed Study Showcasing Best Practices in Full-Spectrum Cannabis Oil Production
LISBON, PORTUGAL, July 1, 2025 /EINPresswire.com/ -- SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, in collaboration with Lusófona University, the largest Portuguese …

Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items required …